Publication:
Nanotechnology-based formulations for resveratrol delivery: Effects on resveratrol in vivo bioavailability and bioactivity

Loading...
Thumbnail Image
Date
2019-04-15
relationships.isAuthorOfPublication
relationships.isSecondaryAuthorOf
relationships.isDirectorOf
Authors
Collado-González, Mar ; Pereira, Irina ; Pereira-Silva, Miguel ; Ferreira, Laura ; Caldas, Mariana ; Magalhães, Mariana ; Figueiras, Ana ; Ribeiro, António J. ; Veiga, Francisco ; Santos, Ana Claudia
item.page.secondaryauthor
item.page.director
Publisher
Elsevier Sci Ltd
publication.page.editor
publication.page.department
DOI
https://doi.org/10.1016/j.colsurfb.2019.04.030
item.page.type
info:eu-repo/semantics/article
Description
©2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ This document is the Accepted version of a Published Work that appeared in final form in Colloids and Surfaces B: Biointerfaces. To access the final edited and published work see https://doi.org/10.1016/j.colsurfb.2019.04.030
Abstract
Resveratrol (RES), also known as 3,5,4′-trihydroxystilbene, is a polyphenolic phytoalexin that has been widely researched in the past decade due to its recognized numerous biological activities. Despite the potential benefits of RES, its effective use is limited due to its poor solubility, photosensitivity and rapid metabolism, which strongly undermine RES bioavailability and bioactivity. Thereby, recently, nanotechnology appeared as a po- tential strategy to circumvent RES physicochemical and pharmacokinetics constrains. However, only few studies have addressed the crucial in vivo suitability of the developed delivery systems to improve RES efficacy. Facing this scenario, in the present review, it is intended to present and discuss the in vivo resveratrol bioavailability and bioactivity, following its encapsulation or conjugation in nanotechnology-based carriers, contemplating their pharmacokinetics effectiveness.
Citation
Colloids and Surfaces B: Biointerfaces 180 (2019) 127–140
item.page.embargo
Collections